Form 4 for WST West Pharmaceutical Services
Accepted 2024-10-31 00:00:00 ET · period of report 2024-10-29 · accession 0001127602-24-026135 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-31 | 2024-10-29 | WST | Abraham Silji | SVP, CTO | M - OptEx | $0.00 | +458.02 | 3,318 | +16% | $0 |
| D | 2024-10-31 | 2024-10-29 | WST | Abraham Silji | SVP, CTO | F - Tax | $318.41 | -180.23 | 3,138 | -5% | -$57.4K |
| D | 2024-10-31 | 2024-10-29 | WST | Abraham Silji | SVP, CTO | M - OptEx | $0.00 | -458.02 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-29 | M | A | 458.02 | $0.00 | 3,318.28 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-29 | F | D | 180.23 | $318.41 | 3,138.05 | D | — | — | |
| 3 | Derivative | Rst. Stock Unit | 2024-10-29 | M | D | 458.02 | $0.00 | 0 | D | $0.00 · — to — | 458.02 Common Stock | (F1) These units were payable in cash or the company's common stock upon the lapse of restrictions on the transaction date shown. |